X
20
Ajinomoto Co., Inc. Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Isoleucine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-122 - Rev 03
This Chemical Type CEP, issued on September 25, 2013, remains in force until March 20, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 770 associated with this CEP further emphasizes